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Purpose. People with obesity, diabetes, and peripheral neuropathy have high levels of intermuscular adipose tissue (IMAT) volume
which has been inversely related to physical function. We determined if IMAT is muscle speciﬁc, if calf IMAT is diﬀerent between
a healthy obese group (HO), a group with diabetes mellitus (D), and a group with diabetes mellitus and peripheral neuropathy
(DN), and if IMAT volume or the ratio of IMAT/muscle volume is related to physical function in these groups. Methods.1 0
healthy obese people, 11 with type 2 diabetes, 24 with diabetes and peripheral neuropathy, had assessments of muscle morphology,
physical function and muscle performance. Results. The gastrocnemius muscle had a higher ratio of IMAT/muscle volume than
any other muscle or compartment. There were no diﬀerences between groups in calf muscle or IMAT volumes. Calf IMAT was
inversely related to physical performance on the 6-minute walk test (r =− 0.47) and physical performance test (r =− 0.36).
IMAT/muscle volume was inversely related to physical performance (PPT, r =− 0.44; 6MW r =− 0.48; stair power, r =− 0.30).
Conclusions.IMATaccumulationvariesincalfmuscles,ishighestinthegastrocnemiusmuscle,andisassociatedwithpoorphysical
performance.
1.Introduction
Previous research has shown that people with obesity,
diabetes, and peripheral neuropathy have signiﬁcantly great-
er amounts of intermuscular adipose tissue (IMAT) in the
calf compared to a nonobese control group and that this
calf IMAT was associated with poor physical performance
[1]. The unique contributions of obesity, diabetes, and
diabetes in combination with peripheral neuropathy to the
amount of IMAT in skeletal muscle, however, are not clear.
In addition, the relationship between calf IMAT and physical
performance is not clear in these groups. IMAT is deﬁned as
the visible adipose tissue beneath muscle fascia and between
muscle groups [2, 3]. IMAT in the thigh has been linked to
insulin resistance and has been described as a unique adipose
tissue depot that is similar to visceral adipose tissue in its
risks for metabolic impairment [4–6], but little is known
about IMAT in the calf muscles. Previous investigators [5, 6]
have shown that IMAT is linked to insulin resistance and
that denervation [7] can also contribute to fat inﬁltration in
muscle, but it is unclear how the combination of obesity, dia-
betes, and peripheral neuropathy impacts IMAT inﬁltration.
It is also unknown whether calf IMAT accumulation is
muscle or muscle compartment speciﬁc, that is, whether
o n em u s c l eo rag r o u po fm u s c l e st e n d st oh a v em o r e
IMAT than others. Identifying preferential diﬀerences in
IMAT accumulation may help to understand the purpose
of IMAT. Muscles in the calf have diﬀerent distributions
of fast twitch and slow twitch ﬁbers. For example, the
gastrocnemius muscle is considered predominantly a fast
twitch muscle and is used more for large force production,
while the soleus muscle is considered more slow twitch and
is a postural muscle that is better suited for using lipids
as a fuel source [8]. It has been shown in animal models
that there is a diﬀerence in fatty acid transport in muscles
with diﬀerent ﬁber type distributions (type I/red muscles
are more oxidative than type II/white) and that fatty acid
transport and triacylglycerides in muscle are impacted by
insulin resistance and diabetes [9]. Additionally, increased
triglyceride storage has been shown in the type I ﬁbers of2 Journal of Aging Research
thesoleusinobeserats[10].Itisunknowninhumanswheth-
er muscles with diﬀerent “predominance” of ﬁber types are
targeted by IMAT inﬁltration in the presence of obesity,
diabetes, and diabetes combined with neuropathy. A better
understanding of IMAT distribution within the calf will pro-
vide us with insight into muscles that may be more compro-
mised by fatty inﬁltration and may lead to improved rehabi-
litation strategies in these populations.
Therefore, the purposes of this study were to determine
if IMAT accumulation is muscle speciﬁc, that is, determine
diﬀerence in IMAT volumes between individual muscles and
muscle compartments, if calf IMAT is diﬀerent between
groups of healthy obese people (HO), a group with diabetes
mellitus (D), and a group with diabetes and peripheral neu-
ropathy (DN), if IMAT and/or the ratio of IMAT/muscle vol-
ume is related to function in these groups. We hypothesized
that the soleus muscle would display more IMAT than
the gastrocnemius muscle and all other calf compartments
across the three groups due to the predominance of slow
twitch ﬁbers and higher lipid oxidation capacity in the soleus
muscle. Additionally, we hypothesized that the D and DN
groups would have greater volumes of IMAT in the calf, and
similar calf muscle volumes compared to the HO group, and
that the DN group would display the largest volume of calf
IMAT of all 3 groups. We hypothesized that calf IMAT vol-
ume would be inversely correlated with measures of physical
performance.
2. Methods and Procedures
2.1. Participants. Forty-ﬁve subjects participated in this
study (Table 1) .T h eg r o u p sw e r em a t c h e df o ra g ea n dB M I .
Initially, there was an analysis of a group of 10DN subjects
who best matched the 10 individuals in the other 2 groups.
However, this did not change the results and increased the
DN group variability. This led to reporting the larger group
of DN subjects.
Participants were recruited from the Washington Univer-
sity School of Medicine Diabetes Clinic, Washington Uni-
versity’s Volunteers for Health, the Center for Community
Based Research, and from diabetes clinics in the surrounding
St. Louis community. This study is part of a larger study
investigating the eﬀect of exercise for people with diabetes
and peripheral neuropathy. Participant characteristics are
listed in Table 1. Participants were excluded if they weighed
more than 300 pounds (equipment weight limit) or had
a history of severe foot deformity or amputation, any co-
morbidity or medications that would interfere with exercise
(such as severe rheumatoid arthritis, peripheral arterial dis-
ease (absent pulses), dialysis, or current cancer treatment).
Participants provided written informed consent. This study
was approved by the Human Research Protection Oﬃce at
Washington University in St. Louis.
3. Assessments
3.1. Peripheral Neuropathy. Presence of peripheral neuropa-
thy was determined based on both an inability to feel
the 5.07 Semmes-Weinstein monoﬁlament on at least one
point on the plantar surface of the foot and on a vibration
perception threshold greater than 25V as measured with a
biothesiometer applied to the plantar surface of the great toe
[11, 12]. All subjects were tested for presence of neuropathy;
to be included in the D and HO groups, subjects had to
be able to feel the 5.07 monoﬁlament and have a vibration
perception threshold below 25V.
3.2. Intermuscular Adipose Tissue (IMAT). Calf intermuscu-
lar adipose tissue volumes were quantiﬁed using MRI on the
right leg of each participant. The MRI scans were perform-
ed with the participant in a supine position with a Siemens
CP extremity coil placed over the right calf muscle. The
MRI measurements were performed with a 3.0 Tessla super-
conducting magnet with a pulse sequence of TE = 12 mil-
liseconds, TR = 1,500 milliseconds, matrix = 256 × 256;
both a fat-saturated and a non-fat-saturated image were col-
lected[1].Thirtytransversesliceswerecollectedbeginningat
the joint space of the knee and proceeding distally. The slices
were 7mm thick with no interslice gap. Nine consecutive
slices were selected to calculate muscle and IMAT volumes.
Volumes were quantiﬁed using a PC workstation and custom
Matlabsoftware.Thesoftwareusesvoxelbrightnesstodistin-
guish between muscle and adipose tissues [6, 13, 14]. The
subcutaneous adipose tissue was removed from each image
by drawing a line along the deep fascial plane surrounding
the calf muscle so that only the fat within and between the
muscles (IMAT) was remaining. The software uses edge de-
tection algorithms to assist the user in separating the sub-
cutaneous fat from the muscle as well as separating indi-
vidual muscles and muscle compartments. In the calf, the
muscle was divided into (1) the anterior compartment, (2)
the lateral compartment, (3) the deep compartment, (4) the
gastrocnemius muscle, and (5) the soleus muscle (Figure 1).
Calf IMAT and calf muscle volumes are reported in cm3.
An additional variable, IMAT per muscle volume, was also
used in analysis. Based on test-retest reliability of 21 subjects
(group included people who are obese, people with diabetes,
and people with diabetes and peripheral neuropathy), the
error in measuring muscle volume is less than 1% and less
than 2% for measuring fat volumes on average in any muscle
or compartment [15].
3.3. Six-Minute Walk Test. All participants performed the
six-minute walk test [16] which was validated previously in
obese adults [17]. The participants walked back and forth in
a hallway between 2 cones that were placed 100 feet (30.5m)
apart. The participants were instructed that the goal was to
walk as far as possible in 6 minutes. Six-minute walk distance
was recorded as total distance walked (in meters).
3.4. Physical Performance Test (PPT). The modiﬁed 9-item
PPT was used to assess physical performance in all partici-
pants. This test is designed to mimic activities of daily
living, and the 9-item PPT has been shown to correlate well
with disability and frailty [18–20]. The 9-item PPT includes
placing a book on a shelf, putting a lab coat on and taking it
oﬀ,pickingupacoinfromtheﬂoor,a25-footwalkdownand
back at a fast speed, turning in a 360-degree circle, simulatedJournal of Aging Research 3
Table 1: Subject demographics by group. Values are means (SD).
Group N Gender (M/F) Age (years) BMI (kg/m2) Weight (lbs)
Diabetes medication
(oral only/insulin and
oral)
HbA1c (%) DM duration (years)
HO 10 4/6 64 (9) 32.9 (4.6) 213 (41) NA 5.8 (0.2) NA
D 11 5/6 56 (9) 35.5 (6.4) 226 (33) 6/5 8.1 (2.2) 8.1 (6.9)
DN 24 15/9 64 (13) 32.6 (6.3) 217 (45) 13/11 7.1 (1.3) 12.9 (9.0)
NA: not applicable.
(a) (b) (c)
Figure 1: (a) MRI image of calf with bone removed. (b) Subcutaneous adipose tissue removed. (c) Calf divided into 5 compartments
(anterior, lateral, deep, gastrocnemius, and soleus).
eating, writing a sentence, climbing a ﬂight of stairs with 10
steps,andsittingtostanding5timesfromalowchair.Eachof
the items is scored on a scale of 0–4 based on the time it takes
to complete the task. Each task is performed twice, and the
average time is used to determine the 0–4 score. A maximum
score is indicated by a score of 36.
3.5. Stair Power Measure. Stair power (in watts) was calcu-
lated based on the time it took each participant to climb
a ﬂight of 10 stairs as part of the PPT (average of 2 trials)
usingthefollowingformulawhichwasadaptedfromthestair
sprinting power test [21]:
Stair Power = 3.171 ∗ Weight

kg

/time (sec)
Climb avg ∗
1
.1383
∗
1
.7378
,
where 3.171 = distance traveled (m),
Climb avg = average time to
climb a ﬂight of 10 stairs (sec),
1
.1383
= conversion
kgm
s
to
ftlbs
s

,
1
.7378
= conversion

ftlbs
s
to Watts

.
(1)
Subjectswereallowedtotouchahandrailforbalance,butnot
for pulling or pushing to ascend the stairs.
3.6. Ankle Dorsiﬂexion and Plantarﬂexion Peak Torque and
Power. Concentric isokinetic ankle dorsiﬂexor and plan-
tarﬂexorpeaktorqueandpowerwereassessedusingaBiodex
Multijoint System 3Pro isokinetic dynamometer. The tests
were performed at angular velocities of 60◦/s. The average
power at 60◦/s was determined by the time-averaged inte-
grated area under the curve at the constant velocity of move-
ment in the available range of motion [1]. All participants
were given 3 practice trials to ensure they were comfortable
with the test. The mean values for peak torque and average
power were calculated for 3 trials.
3.7. Statistical Methods. Statistical analyses were performed
using Systat for windows, version 13.0. An analysis of vari-
ance was used to examine the main and interaction eﬀects of
calf IMAT and muscle volumes (gastrocnemius, soleus, ante-
rior compartment, lateral compartment, and deep compart-
ment), group (HO, D, DN), and measures of physical per-
formance. Post hoc t-tests were used to examine diﬀerences
in groups (HO, D, and DN) on the variables of calf IMAT
volume, calf muscle volumes, and physical performance as
needed based on the results of the ANOVA. A Pearson corre-
lationwasusedtoexaminetheassociationsbetweenvariables
across all 45 subjects—all scatter plots were inspected and
analyzed for outliers. Signiﬁcance level was set at P = 0.05.
4. Results
There were no group diﬀerences in age, BMI, or weight
(P>0.05). The HO group was signiﬁcantly diﬀerent from
the other groups in HbA1c and DM duration—the D and4 Journal of Aging Research
Table 2: ANOVA results: muscle morphology measures; all values are means (SD) in cm3.
HO D DN P values
Muscle volume 404 (90) 434 (72) 407 (88) 0.65
IMAT volume 67 (54) 65 (36) 70 (40) 0.94
Anterior compartment muscle volume 62 (9) 69 (15) 65 (14) 0.57
Anterior compartment IMAT volume 7 (5) 10 (11) 9 (5) 0.53
Lateral compartment muscle volume 36 (10) 38 (9) 37 (11) 0.85
Lateral compartment IMAT volume 6 (5) 5 (3) 7 (4) 0.62
Deep compartment muscle volume 51 (15) 54 (13) 60 (12) 0.15
Deep compartment IMAT volume 9 (6) 8 (4) 11 (5) 0.23
Soleus muscle volume 127 (28) 130 (26) 118 (32) 0.46
Soleus IMAT volume 14 (14) 14 (8) 15 (10) 0.97
Gastroc. muscle volume 128 (31) 142 (27) 122 (40) 0.35
Gastroc. IMAT volume 31 (28) 27 (15) 28 (21) 0.90
IMAT/muscle volume 0.144 (0.07) 0.158 (0.11) 0.193 (0.16) 0.58
Anterior compartment: comprised of tibialis anterior, extensor digitorum longus, and extensor hallucis longus muscles.
Lateral compartment: comprised of peroneus longus and brevis muscles.
Deep compartment: comprised of the tibialis posterior, ﬂexor digitorum longus, and ﬂexor hallucis longus muscles.
Table 3: ANOVA results: physical performance measures. Values
are means (SD).
HO D DN P values
DFPT (Nm) 5.2 (4.3) 15.3 (7.5)a 4.5 (5.3) 0.00
DFPOW (W) 2.3 (2.4) 9.8 (6.6)a 2.2 (3.2) 0.00
PFPT (Nm) 58.0 (18.6) 48.1 (13.0) 51.4 (16.5) 0.37
PFPOW (W) 45.9 (15.1) 38.7 (10.9) 41.9 (18.1) 0.38
6MW (m) 512.4 (48)a 459.6 (80) 425.5 (98) 0.04
PPT 34 (1.5) 31 (2.4) 28 (4.0) 0.001∗
Stair power (W) 808 (327) 671 (163) 601 (226) 0.04∗
∗Indicates all 3 groups are diﬀerent.
aIndicates that the group is diﬀerent from the other 2 groups.
DFPT: dorsiﬂexor peak torque; DFPOW: dorsiﬂexor power; PFPT: plan-
tarﬂexor peak torque; PFPOW: plantarﬂexor power; 6MW: six-minute walk
distance; PPT: physical performance test (9 items).
DN groups were not signiﬁcantly diﬀerent on these meas-
ures. The gastrocnemius muscle had a higher ratio of IMAT/
muscle volume than any other muscle or compartment (P =
.005) across all participants (Table 2).
There were no group diﬀerences between any of the
calf muscle or IMAT volume measures (Table 2). Group
diﬀerences were determined for descriptive purposes and are
contained in Table 3.
Across all participants, calf IMAT volume was associated
with BMI (r = 0.31) and IMAT volume was associated
with poorer physical performance on the 6-minute walk test
(r =− 0.47) and the physical performance test (r =− 0.36).
IMAT/muscle volume was also associated with poor physi-
cal performance (PPT r =− 0.44, 6MW r =− 0.48). Muscle
volume was not strongly associated with 6-minute walk dis-
tance or physical performance test score but was associated
with stair power (r = 0.51) (Table 4).
5. Discussion
This study is the ﬁrst to report that the amount of IMAT/
muscle volume in the calf is muscle and compartment
speciﬁc in the pathologies of obesity, diabetes, and diabetes
combined with peripheral neuropathy. The gastrocnemius
muscle had the largest ratio of IMAT/muscle volume com-
pared to any of the calf muscles and compartments, which
was contrary to what we expected and to what has been
reported in obese animal models [9, 10]. We speculate that
perhaps those muscles with a predominance of fast-twitch
ﬁbers, such as the gastrocnemius muscle, are aﬀected by
IMAT accumulation preferentially or sequentially. The plan-
tar ﬂexor muscles are important for ankle stability, walking
velocity, and cadence [22]. Furthermore, the gastrocnemius
is used during powerful and phasic/burst type activity com-
pared to the soleus muscle which is most active for postural
control.PerhapsthegastrocnemiusismoreaﬀectedbyIMAT
than the soleus muscle due to a greater reduction in power
activities compared to postural activities in these groups. Or,
perhaps the reduced lipid metabolism in the gastrocnemius
muscle compared to the soleus muscle results in greater
IMAT storage rather than lipid oxidation. Additional studies
are required to determine the underlying mechanisms for
the IMAT accumulation in the gastrocnemius muscle and its
propensity for having greater fat inﬁltration than other calf
muscles. Understanding the muscle speciﬁc distribution of
fat and the underlying mechanisms for fat inﬁltration may
lead to enhanced treatment strategies to improve the health
of the muscle and individual. For example, Marcus et al. [23]
demonstrated that people with type 2 diabetes were able to
improve performance, decrease fat, and increase lean tissue
in the thigh muscles after a 16-week exercise program that
included both aerobic and high-intensity eccentric exercise
training. Perhaps speciﬁc rehabilitation strategies that target
the gastrocnemius muscle could alter the fat inﬁltration andJournal of Aging Research 5
Table 4: Correlation matrix.
IMAT vol 6MW PPT Stair POW Muscle Vol IMAT/Mus Vol
BMI 0.31∗ −0.18 0.01 0.21 0.49∗ 0.08
IMAT vol −0.47∗ −0.36∗ −0.18 −0.32∗ 0.93∗
6MW 0.79 ∗ 0.58∗ 0.25 −0.48∗
PPT 0.60∗ 0.24 −0.44∗
Stair Pow 0.51∗ −0.30∗
Muscle vol −0.35∗
∗Indicates signiﬁcance (P<0.05).
IMAT: intermuscular adipose tissue volume; 6MW: six-minute walk distance; PPT: physical performance test (9 items); Stair Pow: stair power; Muscle Vol:
calf muscle volume; IMAT/MusVol: ratio of IMAT/muscle volume in the calf.
improve deﬁcits in muscle performance and physical per-
formance.
Overall, the inverse correlation between calf IMAT vol-
ume and physical performance indicates that IMAT accumu-
lation is associated with physical performance decline, but
it appears that there are other factors, such as the presence
of diabetes and/or neuropathy, that are key mediators of
physicalperformance.TheratioofIMAT/musclevolumewas
inversely related to measures of muscle performance across
all subjects. The ratio of calf IMAT/muscle volume may be
an indicator of physical performance, but the IMAT/Muscle
volume does not diﬀer between those with diabetes and
diabetes and neuropathy compared to a healthy obese group
of subjects. These results are consistent with other reports
in the literature and suggest measures other than absolute
muscle volume or muscle cross-sectional area are needed to
completely characterize calf muscle composition and muscle
performance [1, 24] and suggest that perhaps IMAT/muscle
volume may be an indicator of “muscle quality.” These
data are also consistent with reports that people with D or
DN have limitations in physical performance and function
beyond what is fully explained by muscle changes alone [24,
25]. Certainly problems secondary to sensory neuropathy
can contribute to these deﬁcits in physical performance [26].
We found, contrary to our expectations, that there were
no group diﬀerences in measures of IMAT volumes or
muscle volumes between a group with HO, a group with D,
and a group with DN. These results indicate that diabetes
and peripheral neuropathy were not associated with IMAT
accumulation in the calf beyond their association with BMI
in these groups of subjects. These results were surprising
because our previous study indicated that a group with
obesity, diabetes, and peripheral neuropathy had two times
the volume of IMAT compared to a nonobese, nondiabetic,
nonneuropathic control group [1]. Four of the six subjects
with DN in that group were sampled from a patient sample
with a history of foot ulcers rather than the community at
large, so it is likely that we were capturing a group with more
severe neuropathy in the previous study compared to what
we report here.
Ofnote,theHOgrouphadanaverageHbA1cvalueof5.8
which is indicative of people at risk for developing diabetes
[27]. This HbA1c value is consistent with other reports in
the literature that link IMAT with insulin resistance [5, 6],
and this marginally high HbA1c value could be a potential
indicator of those at risk for developing diabetes. Interest-
ingly, the HO group had higher levels of physical perfor-
mance than the D or DN groups, so perhaps an intervention
targeted at minimizing IMAT could diminish risk for deve-
loping diabetes and mitigate the functional decline that is as-
sociated with diabetes and diabetes and peripheral neuro-
pathy.
There are limitations that should be considered. First, we
have a relatively small sample size. Based on the small eﬀect
size between groups, a post hoc power analysis revealed that
we would need to collect data on more than 3600 individuals
to be powered to ﬁnd group diﬀerences in total IMAT in
the calf with a power of 0.80 and an alpha level at 0.05.
ThemagnitudeandimpactofIMATaccumulationinspeciﬁc
calf muscles or compartments in people with severe diabetes
and peripheral neuropathy requires additional investigation.
We are limited in our ability to interpret results because we
do not have biopsies or other biochemical measures of the
individual muscles or adipose tissues to further elucidate
characteristics beyond our macroscopic MRI measures. This
study is also limited in that we do not have a measure of
activity level for each participant, so it is possible that our
groupscouldbediﬀerentfromeachotherinlevelsofactivity.
Future studies should characterize subjects on activity level,
activity types (endurance versus strengthening exercise), and
neuropathy severity to enhance interpretation of results.
We do not have electrodiagnostic measures of neuropathy,
and it possible that electrodiagnostic measures would have
provided us with a more accurate measure of neuropathy
severity including a measure of subclinical neuropathy in the
D or HO groups. Since the group with DN was originally
recruited for an exercise study, it is possible that we have
a selection bias towards people with DN who are higher
functioning. In addition, this group only had 2 people with a
historyofplantarfootulcer,sowedonotbelievetheseresults
are generalizable to people with more severe complications
and longer durations of diabetes and peripheral neuropathy.
Lastly, the correlations between the diﬀerent variables only
indicate association and cannot determine cause and eﬀect.
In conclusion, this study found that increased calf IMAT
volumeaccumulationwasmusclespeciﬁc;thegastrocnemius
muscle had the largest ratio of IMAT/muscle volume of
all of the calf muscles and compartments. In addition, calf6 Journal of Aging Research
IMAT was associated with poorer physical performance. The
groups with D and DN had lower measures of physical per-
formance than the HO group, suggesting that more severe
impairment in metabolic pathology, along with IMAT accu-
mulation, impacts physical performance.
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